These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30851385)

  • 1. Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I.
    Meruva S; Thool P; Shah S; Karki S; Bowen W; Ghosh I; Kumar S
    Int J Pharm; 2019 Sep; 568():118189. PubMed ID: 30851385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downstream processing of irbesartan nanocrystalline suspension and mini-tablet development - Part II.
    Meruva S; Thool P; Karki S; Bowen W; Ghosh I; Kumar S
    Int J Pharm; 2019 Sep; 568():118509. PubMed ID: 31301463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of wetting agents and disintegrants in development of danazol nanocrystalline tablets.
    Meruva S; Thool P; Gong Y; Karki S; Bowen W; Kumar S
    Int J Pharm; 2020 Mar; 577():119026. PubMed ID: 31940456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Vitro and In Vivo Performance of Different Sized Spray-Dried Crystalline Itraconazole.
    Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    J Pharm Sci; 2015 Sep; 104(9):3018-28. PubMed ID: 25195539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incorporation of itraconazole nano-co-crystals into multiparticulate oral dosage forms.
    Huang Z; Staufenbiel S; Bodmeier R
    Eur J Pharm Biopharm; 2022 Jul; 176():75-86. PubMed ID: 35598769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and performance of danazol nano-crystalline suspensions and spray dried powders.
    Kumar S; Jog R; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    Pharm Res; 2015 May; 32(5):1694-703. PubMed ID: 25385690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization and dissolution performance of spray-dried naproxen nano-crystals.
    Kumar S; Shen J; Zolnik B; Sadrieh N; Burgess DJ
    Int J Pharm; 2015; 486(1-2):159-66. PubMed ID: 25814034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive quality by design approach for stable nanocrystalline drug products.
    Jog R; Burgess DJ
    Int J Pharm; 2019 Jun; 564():426-460. PubMed ID: 31026489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and drying of miconazole and itraconazole nanosuspensions.
    Cerdeira AM; Mazzotti M; Gander B
    Int J Pharm; 2013 Feb; 443(1-2):209-20. PubMed ID: 23291552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation parameters of crystalline nanosuspensions on spray drying processing: a DoE approach.
    Kumar S; Xu X; Gokhale R; Burgess DJ
    Int J Pharm; 2014 Apr; 464(1-2):34-45. PubMed ID: 24447788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downstream drug product processing of itraconazole nanosuspension: Factors influencing tablet material properties and dissolution of compacted nanosuspension-layered sugar beads.
    Tan EH; Parmentier J; Low A; Möschwitzer JP
    Int J Pharm; 2017 Oct; 532(1):131-138. PubMed ID: 28859940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets.
    Salazar J; Müller RH; Möschwitzer JP
    Eur J Pharm Sci; 2013 Jul; 49(4):565-77. PubMed ID: 23587645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole.
    Kumar S; Shen J; Burgess DJ
    J Control Release; 2014 Oct; 192():95-102. PubMed ID: 25009979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spray granulation: importance of process parameters on in vitro and in vivo behavior of dried nanosuspensions.
    Figueroa CE; Bose S
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1046-55. PubMed ID: 23916460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in Dissolution Rate of Zotepine via Nanomilling Process - Impact of Dried Nanocrystalline Suspensions on Bioavailability.
    Parmar K; Oza K
    AAPS PharmSciTech; 2021 Dec; 23(1):20. PubMed ID: 34907489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites.
    Azad M; Arteaga C; Abdelmalek B; Davé R; Bilgili E
    Drug Dev Ind Pharm; 2015; 41(10):1617-31. PubMed ID: 25347144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro/in vivo evaluation of felodipine micropowders prepared by the wet-milling process combined with different solidification methods.
    Meng J; Li S; Yao Q; Zhang L; Weng Y; Cai C; Xu H; Tang X
    Drug Dev Ind Pharm; 2014 Jul; 40(7):929-36. PubMed ID: 23614872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ; Gajera BY; Dave RH
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption.
    Sarnes A; Kovalainen M; Häkkinen MR; Laaksonen T; Laru J; Kiesvaara J; Ilkka J; Oksala O; Rönkkö S; Järvinen K; Hirvonen J; Peltonen L
    J Control Release; 2014 Apr; 180():109-16. PubMed ID: 24566254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel redispersible nanosuspensions stabilized by co-processed nanocrystalline cellulose-sodium carboxymethyl starch for enhancing dissolution and oral bioavailability of baicalin.
    Xie J; Luo Y; Liu Y; Ma Y; Yue P; Yang M
    Int J Nanomedicine; 2019; 14():353-369. PubMed ID: 30655668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.